CHRS Congressional Stock Trades

Coherus BioSciences, Inc. (CHRS)

Last disclosed trade Jan 23

Every disclosed trade in CHRS by members of Congress under the STOCK Act, parsed by Coldpine. Informational only, sourced from public filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Shri Thanedar · Sold $CHRS · Jan 23 · $15K–$50K

0.48LOW

Disclosure speedx 0.250.60

Trade sizex 0.250.50

Cluster activityx 0.150.00

Track recordx 0.350.59

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow $CHRS

Get notified when any member of Congress trades $CHRS. Free, no card, no spam.

Follow free →

Disclosed trades

Buys

Sells

Members trading

The record on $CHRS

Coldpine has parsed 1 disclosed trade in $CHRS by 1 member of Congress, drawn from 1 periodic transaction report dated Jan 23, 2023. It came from the House, filed by a Democrat.

The one trade with a known filing lag was reported 17 days after the trade date, inside the 45-day window the STOCK Act sets: a $CHRS sale by Shri Thanedar dated Jan 23, 2023, disclosed Feb 9, 2023. How late filing is measured across all of Congress is in the late-filers study.

Members who trade CHRS

Shri Thanedar1

Recent disclosed trades in CHRS

Date	Member	Type	Amount
Jan 23	Shri Thanedar(MI)	sell	$15K–$50K

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →